Skip to main content

Table 3 Clinic, demographic and laboratory data by diabetic retinopathy classification according to geographic region

From: Regional differences in the prevalence of diabetic retinopathy: a multi center study in Brazil

Variables

DR absent

Mild NPDR

Moderate NPDR

Sever NPDR

Proliferative DR

p value

Duration of diabetes, years

Mean (SD)

 Southeast

14.2 ± 8.6*

19.0 ± 9.6**

22.3 ± 8.7

22.8 ± 7.8

25.7 ± 9.5

0.000

 South

14.1 ± 9.3##

20.5 ± 9.5

19.8 ± 6.1

19.0 ± 0.0

25.7 ± 8.5

 

 North and Northeast

10.7 ± 6.8+

15.9 ± 7.3

15.5 ± 9.0**

15.3 ± 8.7

20.0 ± 7.9

 

 Midwest

10.0 ± 6.6*

17.3 ± 7.1**

22.0 ± 6.8

23.6 ± 9.2

 

Level of HbA1c (%)

Mean (SD)

 Southeast

8.7 ± 2.0***

9.3 ± 2.2

9.5 ± 2.6

8.4 ± 1.1

8.6 ± 1.4

0.012

 South

8.8 ± 1.9

9.4 ± 2.1

10.0 ± 3.5

10.4 ± 0.0

8.9 ± 1.6

0.388

 North and Northeast

9.0 ± 2.1###

9.1 ± 2.3###

11.1 ± 2.5

10.9 ± 3.6

9.5 ± 2.5

0.002

 Midwest

9.1 ± 2.2

9.0 ± 2.1

9.5 ± 1.5

8.9 ± 1.8

0.698

Level of education, years

Mean (SD)

 Southeast

12.1 ± 3.3

11.8 ± 3.9

12.1 ± 3.8

11.5 ± 1.9

11.9 ± 3.8

0.850

 South

12.3 ± 3.6

12.3 ± 4.2

10.5 ± 3.8

13.0 ± 0.0

11.7 ± 5.1

0.307

 North and Northeast

12.7 ± 3.9###

11.7 ± 4.1

10.0 ± 3.7

13.3 ± 4.6

11.2 ± 4.0

0.003

 Midwest

13.1 ± 3.5

13.7 ± 5.3

12.3 ± 6.7

13.6 ± 4.7

0.736

BMI

Mean (SD)

 Southeast

24.0 ± 3.9#

25.1 ± 4.9

26.3 ± 4.9

23.0 ± 6.3

26.3 ± 6.1

0.002

 South

23.9 ± 4.0++

26.0 ± 2.8

24.5 ± 4.2

24.9 ± 0.0

25.1 ± 3.7

0.006

 North and Northeast

23.3 ± 3.4

24.4 ± 4.2

24.9 ± 4.1

22.8 ± 1.3

23.0 ± 3.8

0.075

 Midwest

23.1 ± 4.2**

24.7 ± 5.1

24.4 ± 3.4

25.8 ± 4.5

0.010

Level of care, n (%)

 Southeast

  Secondary

77 (70.6%)

18 (16.5%)

12 (11.0%)a

2 (1.8%)

0 (0.0%)

0.000

  Tertiary

352 (62.5%)

111 (19.7%)

32 (5.7%)

4 (0.7%)

64 (11.4%)d

 

 South

  Secondary

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

 

  Tertiary

136 (57.1%)

45 (18.9%)

20 (8.4%)

1 (0.4%)

36 (15.1%)

 

 North and Northeast

0.000

  Secondary

254 (63.0%)

69 (17.1%)c

29 (7.2%)

3 (0.7%)

48 (11.9%)f

 

  Tertiary

175 (83.3%)e

18 (8.6%)

10 (4.8%)

3 (1.4%)

4 (1.9%)

 

 Midwest

  Secondary

74 (58.3%)

29 (22.8%)

7 (5.5%)

17 (13.4%)

 

  Tertiary

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

 

Physical activity, n (%)

 Southeast

  Yes

96 (62.7%)

30 (19.6%)

13 (8.5%)

2 (1.3%)

12 (7.8%)

0.627

  No

333 (64.2%)

98 (18.9%)

31 (6.0%)

4 (0.8%)

53 (10.2%)

 

 South

  Yes

26 (44.8%)

11 (18.9%)

9 (15.5%)

0 (0.0%)

12 (20.7%)

0.066

  No

110 (61.1%)

34 (19.0%)

11 (6.1%)

1 (0.6%)

24 (13.3%)

 

 North and Northeast

  Yes

132 (74.6%)

26 (14.7%)

9 (5.1%)

1 (0.6%)

9 (5.1%)

0.278

  No

297 (68.3%)

61 (14.0%)

30 (6.9%)

4 (0.9%)

43 (9.9%)

 

 Midwest

  Yes

13 (50.0%)

8 (30.8%)

1 (3.8%)

4 (15.4%)

0.658

  No

61 (60.4%)

21 (20.8%)

6 (5.9%)

13 (12.9%)

 

Smoking, n (%)

 Southeast

  Yes

51 (50.0%)

25 (24.5%)

8 (7.8%)

2 (2.0%)

16 (15.7%)a

0.048

  No

429 (66.1%)c

119 (18.3%)

41 (6.3%)

4 (0.6%)

56 (8.6%)

 

 South

  Yes

26 (45.6%)

10 (17.5%)

9 (15.8%)a

0 (0.0%)

12 (21.1%)

0.049

  No

99 (61.5%)a

31 (19.3%)

9 (5.6%)

1 (0.6%)

21 (13.0%)

 

 North and Northeast

  Yes

34 (68.0%)

5 (10.0%)

4 (8.0%)

1 (2.0%)

6 (12.0%)

0.425

  No

297 (70.4%)

62 (14.7%)

26 (6.2%)

3 (0.7%)

34 (8.1%)

 

 Midwest

  Yes

9 (47.4%)

6 (31.6%)

2 (10.5%)

2 (10.5%)

0.405

  No

110 (59.8. %)

40 (21.7%)

9 (4.9%)

25 (13.6%)

 

Hypercholesterolemia, n (%)

 Southeast

  Yes

99 (52.1%)

43 (22.6%)

23 (12.1%)d

2 (1.1%)

23 (12.1%)

0.000

  No

380 (68.0%)g

100 (17.9%)

26 (4.7%)

4 (0.7%)

49 (8.8%)

 

 South

  Yes

23 (46.9%)

6 (12.2%)

5 (10.2%)

1 (2.0%)

14 (28.6%)b

0.009

  No

102 (60.4%)

35 (20.7%)

13 (7.7%)

0 (0.0%)

19 (11.2%)

 

 North and Northeast

  Yes

32 (43.2%)

16 (21.6%)a

9 (12.2%)a

2 (2.7%)

15 (20.3%)g

0.000

  No

297 (75.0%)e

51 (12.9%)

21 (5.3%)

2 (0.5%)

25 (6.3%)

 

 Midwest

  Yes

17 (44.7%)

10 (26.3%)

3 (7.9%)

8 (21.1%)

0.176

  No

102 (61.8%)

36 (21.8%)

8 (4.8%)

19 (11.5%)

 

Hypertension, n (%)

 Southeast

  Yes

47 (33.6%)

37 (26.4%)a

22 (15.7%)i

2 (1.4%)

32 (22.9%)j

0.000

  No

433 (70.9%)h

107 (17.5%)

27 (4.4%)

4 (0.7%)

40 (6.5%)

 

 South

  Yes

19 (33.3%)

11 (19.3%)

7 (12.3%)

1 (1.8%)

19 (33.3%)f

0.000

  No

106 (65.8%)f

30 (18.6%)

11 (6.8%)

0 (0.0%)

14 (8.7%)

 

 North and Northeast

  Yes

16 (28.1%)

17 (29.8%)d

8 (14.0%)

0 (0.0%)

16 (28.1%)e

0.000

  No

313 (75.8%)k

50 (12.1%)

22 (5.3%)

4 (1.0%)

24 (5.8%)

 

 Midwest

  Yes

9 (26.5%)

10 (29.4%)

4 (11.8%)

11 (32.4%)d

0.000

  No

110 (65.1%)f

36 (21.3%)

7 (4.1%)

16 (9.5%)

 
  1. Data are presented as the means (SD) and N (%)
  2. DR diabetic retinopathy, NPDR non-proliferative diabetic retinopathy, BMI body mass index
  3. * p < 0.006 vs every other DR, ** p < 0.004 vs proliferative DR, *** p < 0.023 vs mild NPDR, #p = 0.032 vs moderate NPDR, ## p < 0.004 vs mild NPDR and proliferative DR, ###p < 0.005 vs moderate NPDR, +p<0.003 vs mild and moderate NPDR and proliferative DR. ++ p < 0.004 vs mild NPDR
  4. aStandard Residual 2.2, b Standard Residual 3.0, c Standard Residual 3.1, d Standard Residual 3.7, e Standard Residual 5.2, f Standard Residual 4.2, g Standard Residual 3.9, h Standard Residual 8.3, i Standard Residual 4.9, j Standard Residual 5.9, k Standard Residual 7.4